SALADINI FRANCESCO | Elenco docenti

Giammarino, F., Paletti, C., Bartolini, N., Fiaschi, L., Biba, C., Varasi, I., et al. (2025). Combined doravirine and islatravir cooperate to inhibit NRTI and NNRTI resistant HIV-1 in vitro. ANTIVIRAL RESEARCH, 239 [10.1016/j.antiviral.2025.106157]. - dettaglio
Fiaschi, L., Biba, C., Varasi, I., Bartolini, N., Paletti, C., Giammarino, F., et al. (2024). In Vitro Combinatorial Activity of Direct Acting Antivirals and Monoclonal Antibodies against the Ancestral B.1 and BQ.1.1 SARS-CoV-2 Viral Variants. VIRUSES, 16(2), 1-12 [10.3390/v16020168]. - dettaglio
Panza, F., Saladini, F., Bartolini, N., Gianmarino, F., Montagnani, F., Spagnuolo, V., et al. (2024). PRESTIGIO RING “a 59-year-old man with multidrug resistant HIV-1 infection failing a regimen including dolutegravir, rilpivirine, atazanavir/cobicistat: successful treatment tailoring based on genotypic and phenotypic resistance tests”. NEW MICROBIOLOGICA, 47(1), 116-122. - dettaglio
Armenia, D., Carioti, L., Micheli, V., Bon, I., Allice, T., Bonura, C., et al. (2024). Comparison of Different HIV-1 Resistance Interpretation Tools for Next-Generation Sequencing in Italy. VIRUSES, 16(9) [10.3390/v16091422]. - dettaglio
Giammarino, F., de Salazar, A., Malet, I., Vinuela, L., Fuentes, A., Saladini, F., et al. (2024). Prevalence and Phenotypic Susceptibility to Doravirine of the HIV-1 Reverse Transcriptase V106I Polymorphism in B and Non-B Subtypes. THE JOURNAL OF INFECTIOUS DISEASES, 229(6), 1796-1802 [10.1093/infdis/jiae010]. - dettaglio

Tutte le pubblicazioni